Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP192692.RA6hMRqiCl-EM67Y4k9tK8o_JK8o_WSLDDTCiV9zABRks130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP192692.RA6hMRqiCl-EM67Y4k9tK8o_JK8o_WSLDDTCiV9zABRks130_assertion type Assertion NP192692.RA6hMRqiCl-EM67Y4k9tK8o_JK8o_WSLDDTCiV9zABRks130_head.
- NP192692.RA6hMRqiCl-EM67Y4k9tK8o_JK8o_WSLDDTCiV9zABRks130_assertion description "[In conclusion, TET2, DNMT3A and ASXL1 mutations are also present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP192692.RA6hMRqiCl-EM67Y4k9tK8o_JK8o_WSLDDTCiV9zABRks130_provenance.
- NP192692.RA6hMRqiCl-EM67Y4k9tK8o_JK8o_WSLDDTCiV9zABRks130_assertion evidence source_evidence_literature NP192692.RA6hMRqiCl-EM67Y4k9tK8o_JK8o_WSLDDTCiV9zABRks130_provenance.
- NP192692.RA6hMRqiCl-EM67Y4k9tK8o_JK8o_WSLDDTCiV9zABRks130_assertion SIO_000772 22905207 NP192692.RA6hMRqiCl-EM67Y4k9tK8o_JK8o_WSLDDTCiV9zABRks130_provenance.
- NP192692.RA6hMRqiCl-EM67Y4k9tK8o_JK8o_WSLDDTCiV9zABRks130_assertion wasDerivedFrom befree-20140225 NP192692.RA6hMRqiCl-EM67Y4k9tK8o_JK8o_WSLDDTCiV9zABRks130_provenance.
- NP192692.RA6hMRqiCl-EM67Y4k9tK8o_JK8o_WSLDDTCiV9zABRks130_assertion wasGeneratedBy ECO_0000203 NP192692.RA6hMRqiCl-EM67Y4k9tK8o_JK8o_WSLDDTCiV9zABRks130_provenance.